These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1895548)

  • 1. Thromboelastographic analysis of coagulation and fibrinolysis in rats with nephrotic syndrome induced by daunomycin.
    Shimizu K
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):491-6. PubMed ID: 1895548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid metabolism in daunomycin-induced nephrotic rats (Part 6)].
    Gomikawa S; Inagaki O; Mori H; Inoue S; Takamitsu Y; Fujita Y
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):239-46. PubMed ID: 8501853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography.
    Kupesiz A; Rajpurkar M; Warrier I; Hollon W; Tosun O; Lusher J; Chitlur M
    Blood Coagul Fibrinolysis; 2010 Jun; 21(4):320-4. PubMed ID: 20400895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chylomicron and VLDL metabolism in daunomycin-induced nephrotic rats].
    Gomikawa S; Hiraoka K; Yamanashi T; Mori H; Fujita Y; Takamitsu Y
    Nihon Jinzo Gakkai Shi; 1995 Jul; 37(7):366-72. PubMed ID: 7637207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Courses of coagulation-fibrinolysis system and renal histological findings in aminonucleoside nephrosis (author's transl)].
    Kikuchi K
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1087-104. PubMed ID: 7321318
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of blood coagulation and fibrinolysis in rheumatoid arthritis using the urokinase activated thromboelastography].
    Motohashi Y; Nakazawa T; Kojima A
    Ryumachi; 1992 Apr; 32(2):123-30. PubMed ID: 1595003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid metabolism in daunomycin induced nephrotic rats. (Part 4)].
    Gomikawa S; Takenaka Y; Nagasaka H; Shono T; Azuma M; Ihara H; Hirabayashi T; Yorifuji R; Inagaki O; Mori H
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):999-1004. PubMed ID: 3244195
    [No Abstract]   [Full Text] [Related]  

  • 8. [Abnormal coagulation and fibrinolytic activities in glomerulonephritis and nephrotic syndrome].
    Nakagawa M; Nishio A
    Nihon Rinsho; 1984 Jun; 42(6):1386-92. PubMed ID: 6482002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid metabolism in daunomycin-induced nephrotic rats (5)].
    Gomikawa S; Inagaki O; Mori H; Fujita Y
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):985-93. PubMed ID: 2263029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid metabolism in daunomycin induced nephrotic rats (Part III)].
    Gomikawa S; Takenaka Y; Shono T; Azuma M; Hirabayashi T; Yorifuji R; Inagaki O; Mori H; Inoue S; Fujita Y
    Nihon Jinzo Gakkai Shi; 1987 Feb; 29(2):243-9. PubMed ID: 3599547
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood coagulation, fibrinolysis and the mercurial nephrotic syndrome.
    Barr RD; Ouna N; Rees PH
    J Trop Med Hyg; 1976 Oct; 79(10):235-6. PubMed ID: 1011317
    [No Abstract]   [Full Text] [Related]  

  • 12. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation and fibrinolysis in rats poisoned with mercuric chloride.
    Michalska M; Mirowski M; Wierzbicki R
    Pol J Pharmacol Pharm; 1988; 40(4):365-71. PubMed ID: 3146750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in blood coagulation and fibrinolysis in the nephrotic syndrome.
    Thomson C; Forbes CD; Prentice CR; Kennedy AC
    Q J Med; 1974 Jul; 43(171):399-407. PubMed ID: 4547474
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasminogen activator in nephrotic syndrome.
    Andreenko GV; Podoroldskaya LV; Polyantseva LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):351-5. PubMed ID: 2465229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid metabolism in primary cultured hepatocytes from daunomycin-nephrotic rats.
    Gomikawa S; Takamitu Y
    Miner Electrolyte Metab; 1998; 24(5):330-6. PubMed ID: 9705569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A model of daunorubicin-induced nephrotic syndrome in the rat].
    Jiang XY
    Zhonghua Yi Xue Za Zhi; 1989 May; 69(5):288-90. PubMed ID: 2804744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinolytic system in patients with nephrotic syndrome].
    Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV
    Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.